BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6833204)

  • 1. Psychosis following cyclobenzaprine use.
    Beeber AR; Manring JM
    J Clin Psychiatry; 1983 Apr; 44(4):151-2. PubMed ID: 6833204
    [No Abstract]   [Full Text] [Related]  

  • 2. Extended-release cyclobenzaprine (Amrix).
    Med Lett Drugs Ther; 2007 Dec; 49(1276):102-3. PubMed ID: 18084153
    [No Abstract]   [Full Text] [Related]  

  • 3. Induction of Psychosis by Cyclobenzaprine.
    Cohen JY; Guilbault A
    Psychopharmacol Bull; 2018 Jun; 48(4):15-19. PubMed ID: 30618472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First episode psychosis following cyclobenzaprine use.
    O'Neil BA; Knudson GA; Bhaskara SM
    Can J Psychiatry; 2000 Oct; 45(8):763-4. PubMed ID: 11086564
    [No Abstract]   [Full Text] [Related]  

  • 5. Low-dose cyclobenzaprine versus combination therapy with ibuprofen for acute neck or back pain with muscle spasm: a randomized trial.
    Childers MK; Borenstein D; Brown RL; Gershon S; Hale ME; Petri M; Wan GJ; Laudadio C; Harrison DD
    Curr Med Res Opin; 2005 Sep; 21(9):1485-93. PubMed ID: 16197668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclobenzaprine in the treatment of acute muscle spasm: review of a decade of clinical experience.
    Katz WA; Dube J
    Clin Ther; 1988; 10(2):216-28. PubMed ID: 3078905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclobenzaprine-induced delirium in two octogenarians.
    Engel PA; Chapron D
    J Clin Psychiatry; 1993 Jan; 54(1):39. PubMed ID: 8428896
    [No Abstract]   [Full Text] [Related]  

  • 8. Time to recovery in patients with acute painful musculoskeletal conditions treated with extended-release or immediate-release cyclobenzaprine.
    Landy S; Altman CA; Xie F
    Adv Ther; 2011 Apr; 28(4):295-303. PubMed ID: 21424735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Torticollis under cyclobenzaprine.
    Reuss R; Reuter I; Jauss M; Fischer F; Muller SC; Stolz E
    Pharmacology; 2009; 84(2):91-2. PubMed ID: 19590258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic profile of once-daily cyclobenzaprine extended-release.
    Darwish M; Hellriegel ET
    Expert Opin Drug Metab Toxicol; 2010 Nov; 6(11):1425-36. PubMed ID: 20883117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin syndrome from the interaction of cyclobenzaprine with other serotoninergic drugs.
    Keegan MT; Brown DR; Rabinstein AA
    Anesth Analg; 2006 Dec; 103(6):1466-8. PubMed ID: 17122225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclobenzaprine with ibuprofen versus ibuprofen alone in acute myofascial strain: a randomized, double-blind clinical trial.
    Turturro MA; Frater CR; D'Amico FJ
    Ann Emerg Med; 2003 Jun; 41(6):818-26. PubMed ID: 12764337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mania in two patients following cyclobenzaprine.
    Harsch HH
    Psychosomatics; 1984 Oct; 25(10):791-3. PubMed ID: 6494401
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroleptic malignant-like syndrome due to cyclobenzaprine?
    Theoharides TC; Harris RS; Weckstein D
    J Clin Psychopharmacol; 1995 Feb; 15(1):79-81. PubMed ID: 7714231
    [No Abstract]   [Full Text] [Related]  

  • 15. Hallucinations in an elderly patient taking recommended doses of cyclobenzaprine.
    Douglass MA; Levine DP
    Arch Intern Med; 2000 May; 160(9):1373. PubMed ID: 10809044
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of mania secondary to propafenone.
    Jack RA
    J Clin Psychiatry; 1985 Mar; 46(3):104-5. PubMed ID: 2579063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute psychosis with amitriptyline and furazolidone.
    Aderhold RM; Muniz CE
    JAMA; 1970 Sep; 213(12):2080. PubMed ID: 5468760
    [No Abstract]   [Full Text] [Related]  

  • 18. Amitriptyline: initial intolerance and subsequent psychosis.
    O'Connel GJ; Campbell PB; Anath JV
    Can Med Assoc J; 1972 Jan; 106(2):115. PubMed ID: 5058883
    [No Abstract]   [Full Text] [Related]  

  • 19. A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: a randomized, double-blind, two-period crossover study in healthy volunteers.
    Darwish M; Chang S; Hellriegel ET
    Clin Ther; 2009 Jan; 31(1):108-14. PubMed ID: 19243711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychiatric side effects of cyclobenzaprine.
    Shprecher D; Sloan CT; Sederholm B
    BMJ Case Rep; 2013 May; 2013():. PubMed ID: 23645641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.